相关实验视频

Updated: Jul 28, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

在Li Fraumeni综合征中具有同步EGFR突变的NSCLC:一个病例报告

Jennifer A Marks1, Stephen V Liu1

  • 1Division of Hematology and Oncology, Georgetown University, Washington, District of Columbia.

JTO clinical and research reports
|May 30, 2023
PubMed
概括

李弗劳梅尼综合征 (LFS) 患者与同步EGFR外原体19删除和外原体20插入NSCLC存在独特的挑战. 奥西默蒂尼布受益于19号外因子的删除,而20号外因子的插入需要手术.

关键词:
案例报告案例报告发生EGFR突变的原因李弗劳梅尼综合症 李弗劳梅尼综合症在NSCLCLC中,我们可以看到.

更多相关视频

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.6K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K